Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis

Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis

Abstract Background Recent evidence suggests that biologic therapy with targeted activity within the Type 2 inflammatory pathway can improve the clinical signs and symptoms of chronic rhinosinusitis with nasal polyposis (CRSwNP). There remains a population in CRSwNP that despite medical therapy and...

Full description

Bibliographic Details
Main Authors: Andrew Thamboo, S. Kilty, I. Witterick, Y. Chan, C. J. Chin, A. Janjua, A. Javer, J. Lee, E. Monterio, B. Rotenberg, J. Scott, K. Smith, D. D. Sommer, L. Sowerby, M. Tewfik, E. Wright, M. Desrosiers
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Chronic Rhinosinusitis
Biologics
Chronic rhinosinusitis with nasal polyposis
Type 2 inflammation
Online Access:https://doi.org/10.1186/s40463-021-00493-2

Internet

https://doi.org/10.1186/s40463-021-00493-2

Similar Items